Publikationen, an denen er mitarbeitet Antonio Gil Moreno (16)

2023

  1. Noninvasive detection of microsatellite instability in patients with endometrial cancer

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2206-2217

2021

  1. M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients

    Gynecologic Oncology, Vol. 161, Núm. 3, pp. 681-686

  2. Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas

    Biomedicine and Pharmacotherapy, Vol. 140

2019

  1. A novel saliva-based mirna signature for colorectal cancer diagnosis

    Journal of Clinical Medicine, Vol. 8, Núm. 12

  2. Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer

    Journal of Proteome Research, Vol. 18, Núm. 3, pp. 1043-1053

2018

  1. Human salivary microRNAs in Cancer

    Journal of Cancer, Vol. 9, Núm. 4, pp. 638-649

2017

  1. Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

    Modern Pathology, Vol. 30, Núm. 1, pp. 134-145

2015

  1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

2014

  1. ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas

    Carcinogenesis, Vol. 35, Núm. 12, pp. 2679-2686

  2. Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

    Molecular Cancer, Vol. 13, Núm. 1

2012

  1. ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas

    Oncogene, Vol. 31, Núm. 45, pp. 4778-4788

  2. Erratum: Molecular markers of endometrial carcinoma detected in uterine aspirates (International Journal of Cancer (2011) 129:11 (2435-2444) DOI: 10.1002/ijc.25901)

    International Journal of Cancer

2011

  1. High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion

    Molecular Cancer Therapeutics, Vol. 10, Núm. 8, pp. 1357-1366

  2. Molecular markers of endometrial carcinoma detected in uterine aspirates

    International Journal of Cancer, Vol. 129, Núm. 10, pp. 2435-2444

2009

  1. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress

    Carcinogenesis, Vol. 30, Núm. 8, pp. 1288-1297

  2. Subtractive proteomic approach to the endometrial carcinoma invasion front

    Journal of Proteome Research, Vol. 8, Núm. 10, pp. 4676-4684